Cost-Utility Analysis of Eprosartan Compared to Enalapril in Primary Prevention and Nitrendipine in Secondary Prevention in Europe—The HEALTH Model
Title:
Cost-Utility Analysis of Eprosartan Compared to Enalapril in Primary Prevention and Nitrendipine in Secondary Prevention in Europe—The HEALTH Model
Author:
Schwander, Björn Gradl, Birgit Zöllner, York Lindgren, Peter Diener, Hans-Christoph Lüders, Stephan Schrader, Joachim Villar, Fernando Antoñanzas Greiner, Wolfgang Jönsson, Bengt
Appeared in:
Value in health
Paging:
Volume 12 (2009) nr. 6 pages 15 p.
Year:
2009
Contents:
Publisher:
International Society for Pharmacoeconomics and Outcomes Research (ISPOR)